Assessment of Accelerometric Measurement Devices for Gait Analysis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to obtain normative accelerometry data during the six minute walk test and a 30 second walk test on healthy subjects in order to determine the accelerometric variables that are the most relevant to describe gait disorders in patient populations. Secondary objectives of this study are to investigate the impact of walking speed and muscle strength on the accelerometric parameters, to assess the reproducibility of the method and to compare accelerometric data obtained with two different devices.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Walking Strategies in Usual Locomotion of Lower Limb Amputees

NCT05420623

Lower Limb Amputation

COMPLETED

Identify Subjects at Risk for Falling Using Acceleration Based Gait Analysis System

NCT00765297

Fall Risk

UNKNOWN EARLY_PHASE1

Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers

NCT07321977

Spinal Muscular Atrophy (SMA) Charcot-Marie-Tooth Muscular Dystrophy +1 more

RECRUITING NA

Training and Testing Database for IMU Based Gait Analysis Methods

NCT07236008

Healthy Subjects or Volunteers

NOT_YET_RECRUITING

Analysis Acceleration/Deceleration Distance Gait Speed Tests in Stroke Survivors

NCT05679011

Stroke Chronic Stroke

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Different walk tests with an accelerometer device

Subjects will performed three walk tests of 50 meter at different speeds, a six minute walk test, a walking test of 30 seconds then a test to measure the maximum force of extension and knee flexion on each leg. The walk tests will be performed with the accelerometer device (Locometrix) worn in a belt

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy ambulant subject
* subject affiliated to a social security system
* subject who signed an informed consent

Exclusion Criteria

* surgery or recent trauma to the lower limbs (under 6 months)
* high performance sport
* chronic treatment alters the strength in the month before inclusion
* pregnant or nursing woman
* person under guardianship or curatorship
* orthopedic, neuromuscular or neurological disease having an impact on the quality of walking

Minimum Eligible Age

5 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes